Navigation Links
Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
Date:6/2/2008

CLEVELAND, Ohio, June 2 /PRNewswire/ -- Simbionix has announced the release of a new and exciting module for its LAP Mentor simulator that gives trainees hands-on experience with different techniques and alternative approaches to the treatment of ectopic pregnancy, tubal sterilization and oophorectomy.

The GYN module is the latest addition to the suite of laparoscopic procedures developed for the LAP Mentor, the world's most advanced laparoscopic surgery simulator. The GYN module makes full use of the LAP Mentor's 3-D real-life graphics and ergonomically designed hardware to provide the most realistic experience of training and learning possible.

The module includes an expandable library of virtual patients with a variety of anatomical anomalies and complications, a complete set of laparoscopic instruments including those unique to GYN procedures, exceptional audio and visual learning aids and a comprehensive set of performance metrics.

In announcing the release of the new module, Simbionix President Ran Bronstein commented: "This demonstrates Simbionix continued commitment to our LAP customers. We are committed to continuous on going development that will keep the LAP Mentor the most advanced laparoscopic system on the market. Our goal is to assure customers unsurpassed value and maximum benefits from their purchase of Simbionix Simulators".

About Simbionix USA Corporation

Simbionix is the industry leader in the development of innovative and effective medical simulation products used for clinical education and training of medical professionals. Simbionix products are designed to accelerate best-practice medical training, advance clinical performance and improve patient safety. The company is committed to continuously innovating and broadening its product offerings with a wide range of training modules, case studies and scenarios, developed in response to the growing importance of clinical training and education as a means of achieving improved patient care.
Additional company information can be found at http://www.simbionix.com

Contact:

Inbal Mazor

VP Marketing

Tel: +972-8-9211177

inbal@simbionix.com


'/>"/>
SOURCE Simbionix
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. 2007 a "Record Year" for Successful Validation Studies of Simbionix Simulators
2. Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
3. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
4. Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition
5. Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic
6. White Paper Advises Pharma Manufacturers on How to Select an Aseptic Fill/Finish Contractor, Avoid the Most Common Mistakes
7. Ground-Breaking Conference Takes on Abortion
8. First European IGRT School Takes Place for Radiotherapy Practitioners in UK
9. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
10. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
11. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... DrugDev believes the only way to achieve real change ... three tenets were on display at the 2nd Annual DrugDev User Summit (hosted by ... and site organizations to discuss innovation and the future of clinical research. , ...
(Date:12/2/2016)... December 2, 2016 The immunohistochemistry (IHC) ... at a CAGR of 7.3% during the forecast period of 2016 ... diagnostic laboratories segment accounted for the largest share of immunohistochemistry (IHC) ... , ... global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies ...
(Date:11/30/2016)... TORONTO , Nov. 30, 2016 /PRNewswire/ - Portage ... Canadian Securities Exchange: PBT.U), is excited to announce ... company focused on developing preclinical ophthalmology assets through ... a potent anti-inflammatory created by Portage Pharmaceuticals Limited ... patients with ocular surface and anterior segment diseases. ...
(Date:11/30/2016)... BEIJING , Nov. 30, 2016 Novogene ... services and solutions with cutting edge next-generation sequencing (NGS) ... a USD $75 Million [515 Million RMB] B round ... Capital Management ( Shenzhen ) Co., Ltd. ... Innovation") and Shanghai Sigma Square Investment Center LP ("Sigma ...
Breaking Biology Technology:
(Date:6/21/2016)... , June 21, 2016 NuData ... the new role of principal product architect and ... the director of customer development. Both will report ... technical officer. The moves reflect NuData,s strategic growth ... response to high customer demand and customer focus ...
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
Breaking Biology News(10 mins):